Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT04850378 Recruiting - Nephrotic Syndrome Clinical Trials

Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome

CAPTAIN
Start date: March 25, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The study aims to describe the biochemical coagulation profile and investigate the effect of Low molecular weight heparin and Apixaban on this profile in patients with nephrotic syndrome.

NCT ID: NCT04849910 Recruiting - Clinical trials for Myelodysplastic Syndromes

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Start date: December 16, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase 1/2a, multicenter, open-label, first-in-human (FIH) study of VOR33 in participants with AML or MDS who are undergoing human leukocyte antigen (HLA)-matched allogeneic hematopoietic cell transplant (HCT).

NCT ID: NCT04848870 Recruiting - Sjögren Syndrome Clinical Trials

Dental and Periodontal Status of Patients With Sjögren's Syndrome.

CB-SJO
Start date: January 12, 2022
Phase:
Study type: Observational

Sjögren's syndrome (SS) is a rare chronic systemic autoimmune disease characterized by destruction of the exocrine glands, including the salivary glands.The lack of saliva exposes the patient to dental caries, and dental wear although this has rarely been shown in Sjögren's patients. Moreover, these patients seem to have more inflammation and gingival recession, although this has not been clearly identified in the literature. Our main objective is to assess the prevalence of dental wear and gingival recession in patients with Sjögren's syndrome by analyzing of the Basic Erosive Wear Examination (BEWE) score for erosions, Basic Erosive Wear Abrasion (BEWA) score for attrition and percentage of sites with periodontal recessions greater than 3 mm in relation to the total number of sites. Our secondary objectives are to investigate a correlation between the prevalence of dental and gingival wear, gingival inflammation, Decayed, Missing, and Filled Teeth (DMFT) index and (1) salivary parameters and (2) oral quality of life. The salivary samples will be kept in a biological collection within the URP2496 for later analysis (biological collection CB-SJO).

NCT ID: NCT04848857 Completed - Clinical trials for Acute Coronary Syndrome

Colchicine for the Stability of Coronary Plaque in Acute Coronary Syndrome (COLOCT)

COLOCT
Start date: May 3, 2021
Phase: Phase 4
Study type: Interventional

Evidence from the COLCOT Trial has shown that anti-inflammatory effect of colchicine reduced the risk of cardiovascular events in patients with recent myocardial infarction. We hypothesized that this might be due to the improvement of the coronary plaque stability by colchicine. Optical coherence tomography (OCT) is the most precise method to detect plaque stability in clinical practice. Thus, the purpose of this study is to evaluate the efficacy and safety of colchicine on improving the stability of coronary plaque in patients with acute coronary syndrome.

NCT ID: NCT04848766 Recruiting - Clinical trials for Coronary Artery Disease

IPD Meta-analysis of De-escalation Treatment Strategy After PCI in ACS

Start date: June 7, 2021
Phase:
Study type: Observational [Patient Registry]

We will perform a systemic review of previously published data and an updated patient-level meta-analysis of studies, including the most recent publications. PubMed, EMBASE, Cochrane Central Register of Controlled Trials, the United States National Institutes of Health registry of clinical trials, and relevant websites were searched for pertinent published studies.

NCT ID: NCT04848324 Completed - Clinical trials for Carpal Tunnel Syndrome

Short-Term Effectiveness of Ultrasound-Guided Corticosteroid Hydrodissection

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

Aim: Steroid injections are remarkably effective as a treatment for carpal tunnel syndrome (CTS) in the short term. The aim of this study was to determine whether hydrodissection would provide an additional clinical effect when used along with a corticosteroid in the short term. Methods: A prospective cohort of patients with CTS were retrospectively evaluated. 28 patients were selected randomly who received ultrasound (US)-guided triamcinolone hydrodissection (3 mL) as intervention group and received US-guided triamcinolone injection (1 mL) as control group, from the data (case-control ratio 1:1). Outcome measures were the Boston Carpal Tunnel Questionnaire (BCTQ), hand grip strength (HGS), fhe cross-sectional area (CSA) of the median nerve and Short Form 12 (SF-12). Assessments were recorded at baseline, 1 and 4 weeks after injection.

NCT ID: NCT04847401 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome

Start date: May 25, 2021
Phase:
Study type: Observational [Patient Registry]

Evaluating any possible relationship between irritable bowel syndrome occurrence and Helicobacter pylori infection

NCT ID: NCT04847141 Terminated - COVID-19 Clinical Trials

A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients

COVID-19
Start date: April 28, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the efficacy of anti-COVID-19 immune globulin (human) 20% (C19-IG 20%) (2 doses) versus placebo with regard to the percentage of asymptomatic participants who remain asymptomatic, i.e., who do not develop symptomatic coronavirus disease 2019 (COVID-19) through Day 14 as per the protocol defined criteria.

NCT ID: NCT04846205 Completed - Stroke Clinical Trials

Relationship Between Sleep Apnea Syndrome and Patent Foramen Ovale Among Victims of Cryptogenic Ischemic Stroke

Start date: March 24, 2021
Phase:
Study type: Observational

Obstructive sleep apnea syndrome (OSAS) and patent foramen ovale (FOP) are considered as risk factors for stroke. OSAS generates a pressure increase in the right cavity during inspiratory efforts, which increases the number of right-left shunt embolus and therefore the risk of stroke. OSA and FOP are often thought as two separate entities, however, due to their high frequencies, they sometimes coexist and can influence the pathophysiology of each other. More researches are needed in this area to confirm this complex association and its role in triggering stroke.

NCT ID: NCT04844242 Recruiting - SARS-CoV2 Infection Clinical Trials

MISC COVID-19 Study in Pediatric Population

COVID-19
Start date: December 23, 2020
Phase:
Study type: Observational

Rationale: Severe Acute Respiratory Syndrome - Coronavirus - 2 (SARS-CoV2) and its related Coronavirus Disease - 19 (COVID-19) has become a health emergency worldwide. The medical community has been concerned since the beginning of the outbreak about the potential impact of COVID-19 in children, especially in those with underlying chronic diseases. Fortunately, COVID-19 has been reported to be less severe in children than in adults. Unfortunately, a new multisystem inflammatory syndrome apparently related to infection with SARS-CoV-2 has recently been reported in older children (known as MIS-C), manifested by severe abdominal pain, cardiac dysfunction and shock. However, the SARS-CoV2 infection and the underlying immunology of COVID-19, its correlation with disease severity and MIS-C in children is not fully explored. Objectives: To perform systems immunology and strain diversity among SARS-CoV2 and MIS-C infected children. Study design: Cross sectional study. Study population: Children attending outpatients units and admitted in wards in pediatric hospitals in Chennai. Main study parameters/endpoints: Immune responses in children with SARS-CoV2 infection and multisystem inflammatory syndrome in children (MIS-C) infection and its association of SARS-CoV2 viral diversity.